Document ID: FDA-2020-N-0907-0003
Agency: fda
Document Type: Notice
Title: Medical Device User Fee Amendments for Fiscal Years 2023 Through 2027;
Public Meeting; Request for Comments
Posted Date: 2020-04-03T04:00Z

[Federal Register Volume 85, Number 65 (Friday, April 3, 2020)]
[Notices]
[Page 18992]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-07016]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2020-N-0907]

Medical Device User Fee Amendments for Fiscal Years 2023 Through 
2027; Public Meeting; Request for Comments

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public meeting; request for comments; postponement.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that the 
public meeting entitled ``Medical Device User Fee Amendments for Fiscal 
Years 2023 Through 2027; Public Meeting; Request for Comments'' that 
appeared in the Federal Register on March 6, 2020, and was scheduled 
for April 7, 2020, is postponed to May 5, 2020, and will take place by 
webcast only.

DATES: The public meeting will take place remotely on May 5, 2020, 
beginning at 9 a.m. EST. Submit either electronic or written comments 
on the medical device user fee program and suggestions regarding the 
commitments FDA should propose for the next reauthorized program by 
June 5, 2020.

FOR FURTHER INFORMATION CONTACT: Ellen Olson, Center for Devices and 
Radiological Health, Food and Drug Administration, Bldg. 66, Rm. 1664, 
10903 New Hampshire Ave., Silver Spring, MD 20993, 301-796-4322, 
ellen.olson@fda.hhs.gov or 044740564c294b54415529577076657061636d674d6a6d706d65706d726177446260652a6c6c772a636b72.

SUPPLEMENTARY INFORMATION: The public meeting entitled ``Medical Device 
User Fee Amendments for Fiscal Years 2023 Through 2027; Public Meeting; 
Request for Comments'' announced in the Federal Register of March 6, 
2020 (85 FR 13165), and scheduled for April 7, 2020, is postponed to 
May 5, 2020, and will take place virtually due to extenuating 
circumstances. There will no longer be an in-person meeting and instead 
the meeting will be held by webcast only. The webcast link and 
connection instructions will be available on the registration web page 
(https://www.fda.gov/medical-devices/workshops-conferences-medical-devices/2020-medical-device-meetings-and-workshops) after April 23, 
2020. Interested participants may continue to register and, if 
applicable, to specify whether they would like to present during a 
particular session or the public comment session.

    Dated: March 31, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020-07016 Filed 4-2-20; 8:45 am]
BILLING CODE 4164-01-P